Ecg Analysis System Cardiologic - Weinmann MEDUCORE Standard2 Instructions For Use Manual

15.7 ECG analysis system CARDIOlogic

Specification
Analysis time (VF/VT)
ECG derivation used for
analysis
Impedance measurement
Response to implanted cardiac
pacemakers
Asystole threshold
Rhythms Scope of sample
Shockable
Coarse VF
944
(> 0.35 mV)
Rapid VT
252
(f>180/min)
Not shockable
Non-shockable
3070
rhythms
Shockable
signals
Shock 1165 (A)
No shock 31 (C)
ECG analysis system
Duration of analysis in the AED mode: 8 s under typical conditions
Duration of analysis VF/VT alarm: 8 s with continuous measurement
Lead II of the pad electrodes is primarily used for analysis. If the pad
electrodes are not attached, lead II of ECG electrodes is used.
Checks electrode contact
Impulses from implanted pacemakers can affect or prevent correct
arrhythmia detection. As a result, not all defibrillatable rhythms may be
detected and shock delivery may not be recommended by the device.
0.2 mV
The effectiveness of the rhythm detector has been validated with a
representative cross-section of ECG data from the following database:
• Creighton University Ventricular Tachyarrhythmia Database
• American Heart Association ECG Database
• MIT-BIH Malignant Ventricular Arrhythmia Database
Effectiveness results are shown in the tables below:
Objectives for
effectiveness
> 90 %
> 75 %
> 99 %
These parameters were determined on the basis of the following
data:
Non-shockable rhythms (normal sinus rhythm (NSR),
supraventricular tachycardia (SVT), atrial fibrillation/flutter
(AF), ventricular extrasystoles (PVC), pacemaker ECG)
11 (B)
3059 (D)
Sensitivity in % Specificity in %
98.31 %
94.05 %
-
MEDUCORE Standard
15 Technical data
-
-
99.64 %
2
EN 181